Showing 13 to 24 of 49 results
Global Blood Shortage: Disparities and the Search for Alternatives
A global blood shortage exists, with Germany alone needing 112 million annual donations. High-income countries donate disproportionately more, while research into artificial blood offers potential solutions but faces challenges in safety and scalability.
Global Blood Shortage: Disparities and the Search for Alternatives
A global blood shortage exists, with Germany alone needing 112 million annual donations. High-income countries donate disproportionately more, while research into artificial blood offers potential solutions but faces challenges in safety and scalability.
Progress
48% Bias Score
CRISPR-Cas9: Revolutionary Gene Editing and Ethical Concerns
CRISPR-Cas9, a gene-editing technology discovered through bacterial immunity research, allows precise DNA modifications with diverse applications, but raises ethical concerns regarding germline editing, as demonstrated by the controversial birth of gene-edited babies in China.
CRISPR-Cas9: Revolutionary Gene Editing and Ethical Concerns
CRISPR-Cas9, a gene-editing technology discovered through bacterial immunity research, allows precise DNA modifications with diverse applications, but raises ethical concerns regarding germline editing, as demonstrated by the controversial birth of gene-edited babies in China.
Progress
16% Bias Score
Gene Editing Successfully Treats Baby's Life-Threatening Disorder
Doctors successfully treated a baby born with a life-threatening urea cycle disorder using a custom gene-editing therapy in Philadelphia, marking a major breakthrough in personalized medicine; the therapy appears to be working, allowing the baby to eat more protein, gain weight, and reach developmen...
Gene Editing Successfully Treats Baby's Life-Threatening Disorder
Doctors successfully treated a baby born with a life-threatening urea cycle disorder using a custom gene-editing therapy in Philadelphia, marking a major breakthrough in personalized medicine; the therapy appears to be working, allowing the baby to eat more protein, gain weight, and reach developmen...
Progress
40% Bias Score
Successful Gene Editing Treats Rare Genetic Disease in Baby
A baby with severe CPS1 deficiency, a rare genetic disorder affecting approximately one in a million infants, received a custom gene-editing therapy using CRISPR base editing, resulting in significant health improvements within months, opening possibilities for treating other rare genetic diseases.
Successful Gene Editing Treats Rare Genetic Disease in Baby
A baby with severe CPS1 deficiency, a rare genetic disorder affecting approximately one in a million infants, received a custom gene-editing therapy using CRISPR base editing, resulting in significant health improvements within months, opening possibilities for treating other rare genetic diseases.
Progress
40% Bias Score
Gene Editing Successfully Treats Baby's Life-Threatening Genetic Disorder
Doctors successfully used a personalized gene-editing therapy to treat baby KJ Muldoon's life-threatening genetic disorder, carbamoyl phosphate synthetase 1 (CPS1), showing potential for treating numerous rare diseases previously untreatable.
Gene Editing Successfully Treats Baby's Life-Threatening Genetic Disorder
Doctors successfully used a personalized gene-editing therapy to treat baby KJ Muldoon's life-threatening genetic disorder, carbamoyl phosphate synthetase 1 (CPS1), showing potential for treating numerous rare diseases previously untreatable.
Progress
40% Bias Score
Successful Gene Editing Treatment for Rare Genetic Disease
A 9.5-month-old baby, KJ Muldoon, successfully received a custom CRISPR-based gene editing therapy for severe CPS1 deficiency, a rare genetic disease affecting approximately one in a million babies. The treatment significantly improved his health, demonstrating the potential of personalized gene the...
Successful Gene Editing Treatment for Rare Genetic Disease
A 9.5-month-old baby, KJ Muldoon, successfully received a custom CRISPR-based gene editing therapy for severe CPS1 deficiency, a rare genetic disease affecting approximately one in a million babies. The treatment significantly improved his health, demonstrating the potential of personalized gene the...
Progress
40% Bias Score
CRISPR Therapy Shows Promise but Faces Rollout Challenges
The first CRISPR-based therapy, approved in late 2023, offers a cure for previously untreatable diseases; however, slow rollout due to manufacturing and accreditation challenges highlights the need for regulatory adaptations and technological advancements in CRISPR enzyme delivery.
CRISPR Therapy Shows Promise but Faces Rollout Challenges
The first CRISPR-based therapy, approved in late 2023, offers a cure for previously untreatable diseases; however, slow rollout due to manufacturing and accreditation challenges highlights the need for regulatory adaptations and technological advancements in CRISPR enzyme delivery.
Progress
36% Bias Score
CRISPR Gene Editing Shows Promise in Treating Rare Infant Disorder
A six-month-old American baby with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare genetic disorder affecting approximately one in a million infants, received a custom CRISPR gene-editing therapy resulting in a reduction of medication dependency and improved health.
CRISPR Gene Editing Shows Promise in Treating Rare Infant Disorder
A six-month-old American baby with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare genetic disorder affecting approximately one in a million infants, received a custom CRISPR gene-editing therapy resulting in a reduction of medication dependency and improved health.
Progress
36% Bias Score
Gaza Bombing Kills 80 Amidst Faltering Ceasefire Talks
Israeli airstrikes in Gaza killed at least 80 people overnight, hindering ceasefire talks during Trump's Middle East visit; meanwhile, Australian politics sees leadership changes in the Liberals and Greens parties.
Gaza Bombing Kills 80 Amidst Faltering Ceasefire Talks
Israeli airstrikes in Gaza killed at least 80 people overnight, hindering ceasefire talks during Trump's Middle East visit; meanwhile, Australian politics sees leadership changes in the Liberals and Greens parties.
Progress
36% Bias Score
Gene Editing Successfully Treats Rare Genetic Disease in Infant
A baby, K.J. Muldoon, born with severe CPS1 deficiency, a rare genetic disease affecting approximately one in a million infants, is thriving after receiving a custom CRISPR-based gene-editing therapy developed by the Children's Hospital of Philadelphia and Penn Medicine, offering hope for millions w...
Gene Editing Successfully Treats Rare Genetic Disease in Infant
A baby, K.J. Muldoon, born with severe CPS1 deficiency, a rare genetic disease affecting approximately one in a million infants, is thriving after receiving a custom CRISPR-based gene-editing therapy developed by the Children's Hospital of Philadelphia and Penn Medicine, offering hope for millions w...
Progress
48% Bias Score
Gene Editing Successfully Treats Baby with Rare Genetic Disorder
US doctors successfully used a customized gene-editing therapy to treat a baby, KJ, with severe CPS1 deficiency, a rare genetic disorder, showing early signs of success and highlighting the potential of gene editing for treating various genetic diseases.
Gene Editing Successfully Treats Baby with Rare Genetic Disorder
US doctors successfully used a customized gene-editing therapy to treat a baby, KJ, with severe CPS1 deficiency, a rare genetic disorder, showing early signs of success and highlighting the potential of gene editing for treating various genetic diseases.
Progress
40% Bias Score
Personalized Gene Editing Shows Promise in Treating Rare Metabolic Disorder
A US baby, KJ, diagnosed with the ultra-rare CPS1 deficiency, received a groundbreaking personalized gene-editing therapy using base editors, showing promising results and offering a new hope for treating such rare metabolic disorders. The treatment was delivered in two doses via lipid nanoparticles...
Personalized Gene Editing Shows Promise in Treating Rare Metabolic Disorder
A US baby, KJ, diagnosed with the ultra-rare CPS1 deficiency, received a groundbreaking personalized gene-editing therapy using base editors, showing promising results and offering a new hope for treating such rare metabolic disorders. The treatment was delivered in two doses via lipid nanoparticles...
Progress
40% Bias Score
Showing 13 to 24 of 49 results